Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound

International Journal of Hyperthermia

Volumn 27, Issue 2, 2011, Pages 140-155

  Negussie, Ayele H ^a   Yarmolenko, Pavel S ^a,b   Partanen, Ari ^a,c   Ranjan, Ashish ^a   Jacobs, Genevieve ^a   Woods, David ^a   Bryant, Henry ^a   Thomasson, David ^a   Dewhirst, Mark W ^d   Wood, Bradford J ^a   Dreher, Matthew R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Duke University   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Doxorubicin (Adriamycin); heat targeted drug delivery (nanoparticles; high intensity focused ultrasound; imageable temperature sensitive liposomes; liposomes); MR imaging

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; DOXORUBICIN; GADOTERIDOL; IMAGEABLE THERMALLY SENSITIVE LIPOSOME; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG MONITORING; DRUG RELEASE; DRUG STABILITY; EXPERIMENTAL RABBIT; HEATING; HIGH INTENSITY FOCUSED ULTRASOUND; IN VIVO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHANTOM; PLASMA; STORAGE TEMPERATURE; TRANSITION TEMPERATURE;

ANIMALS; CONTRAST MEDIA; DOXORUBICIN; GADOLINIUM; HETEROCYCLIC COMPOUNDS; HUMANS; KINETICS; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; ORGANOMETALLIC COMPOUNDS; PHANTOMS, IMAGING; RABBITS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79951593867     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.528140     Document Type: Article

References (59)

1. Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004;303:1818-1822. (Pubitemid 38374867)
2. Tilcock C. Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. Adv Drug Deliv Rev 1999;37:33-51. (Pubitemid 29164498)
3. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers - advantages of macromolecular therapeutics in vivo. Bioconjugate Chem 1992;3:351-362.
4. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer-chemotherapy - mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986;46:6387-6392. (Pubitemid 17221789)
5. Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD. Doxorubicin encapsulated in liposomes containing surfacebound polyethylene glycol: Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 1996;36:55-63. (Pubitemid 26058811)
6. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-763. (Pubitemid 37328910)
7. Negussie AH, Miller JL, Reddy G, Drake SK, Wood BJ, Dreher MR. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release 2010;2:265-273.
8. Simoes S, Moreira JN, Fonseca C, Duzgunes N, de Lima M C P. On the formulation of pH-sensitive long circulation times. Adv Drug Del Rev 2004;56:947-965. (Pubitemid 38520203)
9. Lokling KE, Fossheim SL, Klaveness J, Skurtveit R. Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness. J Control Release 2004;98:87-95. (Pubitemid 38881610)
10. Spratt T, Bondurant B, O'Brien DF. Rapid release of liposomal contents upon photoinitiated destabilization with UV exposure. BBA-Biomembranes 2003;1611:35-43. (Pubitemid 36351430)
11. Shum P, Kim JM, Thompson DH. Phototriggering of liposomal drug delivery systems. Adv Drug Del Rev 2001;53:273-284. (Pubitemid 34024910)
12. Jensen SS, Andresen TL, Davidsen J, Hoyrup P, Shnyder SD, Bibby MC, Gill JH, Jorgensen K. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol Cancer Ther 2004;3:1451-1458. (Pubitemid 39562590)
13. Pak CC, Erukulla RK, Ahl PL, Janoff AS, Meers P. Elastase activated liposomal delivery to nucleated cells. BBABiomembranes 1999;1419:111-126. (Pubitemid 29322703)
14. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978;202:1290-1293. (Pubitemid 9154441)
15. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000;60:1197-1201. (Pubitemid 30151982)
16. Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, Dellian M. Novel temperaturesensitive liposomes with prolonged circulation time. Clin Cancer Res 2004;10:2168-2178. (Pubitemid 38375579)
17. Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, Pruitt AF, Klein A, Case B, Thrall DE, et al. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res 2006;12:4004-4010. (Pubitemid 44078087)
18. Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: A novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009;10:333-343.
19. Celsion. A phase I dose escalation tolerability study of ThermoDox TM (thermally sensitive liposomal doxorubicin) in combination with radiofrequency ablation (RFA) of primary and metastatic tumors of the liver. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00441376 (accessed 14 February 2010).
20. National Cancer Institute. A phase I dose escalation study of heat activated liposome delivery of doxorubicin and radiofrequency ablation of primary and metastatic tumors of the liver. Available from: http://www. clinicaltrials.gov/ct2/show/NCT00093444 (accessed 14 February 2010).
21. ® (thermally sensitive liposomal doxorubicin) in combination with radiofrequency ablation (RFA) compared to RFA-alone in the treatment of non-resectable hepatocellular carcinoma. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00617981 (accessed 14 February 2010).
22. Duke University and National Cancer Institute. A phase I, dose escalation and pharmacokinetics study of temperature sensitive liposome encapsulated doxorubicin (ThermoDox TM) and hyperthermia in patients with local-regionally recurrent breast cancer. Available from: http://www.clinicaltrials.gov/ct2/show/ NCT00346229 (accessed 14 February 2010).
23. Hand JW. Principles of ultrasound used for generating localized hyperthermia. In: Field SB and Hand JW, editors. An Introduction to the Practical Aspects of Clinical Hyperthermia. London: Taylor & Francis; 1990. pp 371-422.
24. McDannold N, Hynynen K, Wolf D, Wolf G, Jolesz F. MRI evaluation of thermal ablation of tumors with focused ultrasound. J Magn Reson Imaging 1998;8:91-100. (Pubitemid 28099564)
25. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Hesley G, Kim HS, Hengst S, Gedroyc WM. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85:22-29. (Pubitemid 43063413)
26. Phillips Healthcare and NICHD. Pilot study of MRI-guided high intensity focused ultrasound ablation of uterine fibroids. MR imageable thermally sensitive liposomes 153 Available from: http://www.clinicaltrials.gov/ct2/show/ NCT00837161 (accessed 20 April 2010).
27. Phillips Healthcare and Phillips Medical Systems. Clinical trial protocol for therapeutic MRI-guided high intensity focused ultrasound ablation of uterine fibroids. Available from: http://www.clinicaltrials.gov/ct2/show/ NCT00897897 (accessed 20 April 2010).
28. Enholm JK, Kohler MO, Quesson B, Mougenot C, Moonen CT, Sokka SD. Improved volumetric MR-HIFU ablation by robust binary feedback control. IEEE Trans Biomed Eng 2010;57:103-113.
29. Schramm W, Yang D, Haemmerich D. Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. Conf Proc IEEE Eng Med Biol Soc 2006;1:5013-5016. (Pubitemid 46521040)
30. Freccero C, Holmlund F, Bornmyr S, Castenfors J, Johansson AM, Sundkvist G, Svensson H, Wollmer P. Laser Doppler perfusion monitoring of skin blood flow at different depths in finger and arm upon local heating. Microvasc Res 2003;66:183-189. (Pubitemid 37373592)
31. Tilcock C, Unger E, Cullis P, MacDougall P. Liposomal Gd-DTPA: Preparation and characterization of relaxivity. Radiology 1989;171:77-80. (Pubitemid 19093047)
32. Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan S. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents - Effect of liposome size and internal gadolinium concentration. Acad Radiol 2008;15:1259-1263.
33. Mulder W J M, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, Koning GA, Nicolay K. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjugate Chem 2004;15:799-806. (Pubitemid 38981954)
34. Laurent S, Elst LV, Thirifays C, Muller RN. Paramagnetic liposomes: Inner versus outer membrane relaxivity of DPPC liposomes incorporating lipophilic gadolinium complexes. Langmuir 2008;24:4347-4351. (Pubitemid 351569049)
35. Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A. New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging. PLoS ONE 2009;4(10):e7628. doi: 10.1371/journal.pone.0007628.
36. Koenig SH, Ahkong QF, Brown RD, Lafleur M, Spiller M, Unger E, Tilcock C. Permeability of liposomal membranes to water - Results from the magnetic-field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic-ions. Magn Reson Med 1992;23:275-286.
37. Frich L, Bjornerud A, Fossheim S, Tillung T, Gladhaug I. Experimental application of thermosensitive paramagnetic liposomes for monitoring magnetic resonance imaging guided thermal ablation. Magn Reson Med 2004;52:1302-1309. (Pubitemid 39612818)
38. Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, Bally MB, Dewhirst MW. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magn Reson Med 2004;51:1153-1162. (Pubitemid 38797000)
39. Ponce AM, Viglianti BL, Yu D, Yarmolenko PS, Michelich CR, Woo J, Bally MB, Dewhirst MW. Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst 2007;99:53-63.
40. De Smet M, Langereis S, den Bosch SV, Grull H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release 2009;1:120-127.
41. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta 1985;816:294-302. (Pubitemid 15047328)
42. Mayer LD, Bally MB, Cullis PR. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 1986;857:123-126. (Pubitemid 16085119)
43. Fenske DB, Maurer N, Cullis P, Liposomes, 2nd edn. Oxford: Oxford University Press; 2003.
44. Bryant LH, Brechbiel MW, Wu CC, Bulte J W M, Herynek V, Frank JA. Synthesis and relaxometry of high-generation (G=5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. J Magn Reson Imaging 1999;9:348-352. (Pubitemid 29115364)
45. Molinelli AR, Madden MC, McGee JK, Stonehuerner JG, Ghio AJ. Effect of metal removal on the toxicity of airborne particulate matter from the Utah Valley. Inhal Toxicol 2002;14:1069-1086. (Pubitemid 35230750)
46. Bluml S, Schad LR, Stepanow B, Lorenz WJ. Spin-lattice relaxation-time measurement by means of a turboflash technique. Magn Reson Med 1993;30:289-295. (Pubitemid 23264606)
47. Salomir R, Palussiere J, Vimeux FC, de Zwart JA, Quesson B, Gauchet M, Lelong P, Pergrale J, Grenier N, Moonen CT. Local hyperthermia with MR-guided focused ultrasound: Spiral trajectory of the focal point optimized for temperature uniformity in the target region. J Magn Reson Imaging 2000;12:571-583.
48. Hindman JC. Proton resonance shift of water in the gas and liquid states. J Chem Phys 1966;44:4582-4592.
49. Mills JK, Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta 2005;1716:77-96. (Pubitemid 41532286)
50. Madden TD, Harrigan PR, Tai LC, Bally MB, Mayer LD, Redelmeier TE, Loughrey HC, Tilcock CP, Reinish LW, Cullis PR. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: A survey. Chem Phys Lipids 1990;53:37-46. (Pubitemid 20104038)
51. Li X, Hirsh DJ, Cabral-Lilly D, Zirkel A, Gruner SM, Janoff AS, Perkins WR. Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta 1998;1415:23-40. (Pubitemid 29050759)
52. Hossann M, Wiggenhorn M, Schwerdt A, Wachholz K, Teichert N, Eibl H, Issels RD, Lindner LH. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta 2007;1768:2491-2499. (Pubitemid 47532029)
53. Port M, Idee JM, Medina C, Robic C, Sabatou M, Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: A critical review. Biometals 2008;21:469-490.
54. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, et al. Safety ACRBRPM. ACR Guidance document for safe MR practices: 2007. Am J Roentgenol 2007;188:1447-1474. (Pubitemid 46866845)
55. Barenholz Y. Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 2003;13:1-8. (Pubitemid 36378121)
56. Allen TM, Cleland LG. Serum-induced leakage of liposome contents. Biochim Biophys Acta 1980;597:418-426. (Pubitemid 10066496)
57. Banno B, Ickenstein LM, Chiu G N C, Bally MB, Thewalt J, Brief E, Wasan EK. The functional roles of poly (ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. J Pharm Sci 2010;99:2295-2308.
58. Gasselhuber A, Dreher MR, Negussie A, Wood BJ, Rattay F, Haemmerich D. Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia 2010;26(5):499-513.
59. Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, Mueller PR, Lee TY. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 2005;234:785-792. (Pubitemid 40250822)